Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Wasserstrom

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Memory B cells and pneumococcal antibody after splenectomyHeather Wasserstrom, James Bussel, Lony C-L Lim, et al.
Ejhaem|November 29, 2023
Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphomaKeri Toner, Carl E Allen, Shweta Jain, et al.
Oncotarget|October 1, 2019
Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapyCaitlin D Lowery, Wayne Blosser, Michele Dowless, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2020
Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)Yung-Jue Bang, Talia Golan, Laetitia Dahan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Memory B cells and pneumococcal antibody after splenectomyHeather Wasserstrom, James Bussel, Lony C-L Lim, et al.
Ejhaem|November 29, 2023
Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphomaKeri Toner, Carl E Allen, Shweta Jain, et al.
Oncotarget|October 1, 2019
Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapyCaitlin D Lowery, Wayne Blosser, Michele Dowless, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2020
Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)Yung-Jue Bang, Talia Golan, Laetitia Dahan, et al.
Pageof 1